Stem cell therapy for chronic lung diseases: Hope and reality

Respiratory Medicine

Volumn 104, Issue SUPPL. 1, 2010, Pages

  Agostini, Carlo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Chronic lung disease; Embryonic stem cells; Haematopoietic stem cells; Stem cell transplantation

Indexed keywords

CD34 ANTIGEN; MICRORNA; STEM CELL ANTIGEN 1; SURVIVIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT STEM CELL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENICITY; LUNG CANCER; LUNG TRANSPLANTATION; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STEM CELL TRANSPLANTATION; TERATOMA; TISSUE ENGINEERING; TISSUE REGENERATION;

CHRONIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES; STEM CELL TRANSPLANTATION;

EID: 77953025562     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.03.022     Document Type: Article

References (35)

1. Rippon H.J., Lane S., Qin M., et al. Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. Proc Am Thorac Soc 5 (2008) 717-722
2. Mirabelli P., Di Noto R., Lo Pardo C., et al. Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies. BMC Physiol 8 (2008) 13
3. Chamberlain G., Fox J., Ashton B., and Middleton J. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007) 2739-2749
4. Fadini G.P., Schiavon M., Avogaro A., and Agostini C. The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 24 (2007) 85-93
5. Fadini G.P., Schiavon M., Cantini M., et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 24 (2006) 1806-1813
6. Loebinger M.R., Aguilar S., and Janes S.M. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond) 114 (2008) 99-108
7. Sueblinvong V., Loi R., Eisenhauer P.L., et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 177 (2008) 701-711
8. Weiss D.J., Kolls J.K., Ortiz L.A., Panoskaltsis-Mortari A., and Prockop D.J. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 5 (2008) 637-667
9. Mattsson J., Jansson M., Wernerson A., and Hassan M. Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell transplantation. Transplantation 78 (2004) 154-157
10. Suratt B.T., Cool C.D., Serls A.E., et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 (2003) 318-322
11. Spencer H., Rampling D., Aurora P., Bonnet D., Hart S.L., and Jaffé A. Transbronchial biopsies provide longitudinal evidence for epithelial chimerism in children following sex mismatched lung transplantation. Thorax 60 (2005) 60-62
12. Xu J., Mora A., Shim H., Stecenko A., Brigham K.L., and Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 37 (2007) 291-299
13. May L.A., Kicic A., Rigby P., et al. Cells of epithelial lineage are present in blood, engraft the bronchial epithelium, and are increased in human lung transplantation. J Heart Lung Transplant 28 (2009) 550-557
14. Zhao Y.D., Courtman D.W., Deng Y., Kugathasan L., Zhang Q., and Stewart D.J. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96 (2005) 442-450
15. Yamada M., Kubo H., Ishizawa K., Kobayashi S., Shinkawa M., and Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 60 (2005) 410-413
16. Wang G., Bunnell B.A., Painter R.G., et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 102 (2005) 186-191
17. Loi R., Beckett T., Goncz K.K., Suratt B.T., and Weiss D.J. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 173 (2006) 171-179
18. Macchiarini P., Jungebluth P., Go T., et al. Clinical transplantation of a tissue-engineered airway. Lancet 372 (2008) 2023-2030
19. Marsboom G., Pokreisz P., Gheysens O., et al. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells 26 (2008) 1017-1026
20. Kidd S., Spaeth E., Klopp A., Andreeff M., Hall B., and Marini F.C. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10 (2008) 657-667
21. Tanjore H., Xu X.C., Polosukhin V.V., et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 180 (2009) 657-665
22. Rippon H.J., Polak J.M., Qin M., and Bishop A.E. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24 (2006) 1389-1398
23. Blum B., and Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 100 (2008) 133-158
24. Blum B., Bar-Nur O., Golan-Lev T., and Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol 27 (2009) 281-287
25. Menendez P., Bueno C., Wang L., and Bhatia M. Human embryonic stem cells: potential tool for achieving immunotolerance?. Stem Cell Rev 1 (2005) 151-158
26. Robertson N.J., Brook F.A., Gardner R.L., Cobbold S.P., Waldmann H., and Fairchild P.J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A 104 (2007) 20920-20925
27. Wu D.C., Boyd A.S., and Wood K.J. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26 (2008) 1939-1950
28. Nehlin J.O., and Barington T. Strategies for future histocompatible stem cell therapy. Biogerontology 10 (2009) 339-376
29. Fairchild P.J. Transplantation tolerance in an age of induced pluripotency. Curr Opin Organ Transplant 14 (2009) 321-325
30. Kim C.F., Jackson E.L., Woolfenden A.E., et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
31. Zhang Y., Goss A.M., Cohen E.D., et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet 40 (2008) 862-870
32. Kim C.F. Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells. Am J Physiol Lung Cell Mol Physiol 293 (2007) L1092-L1098
33. Yanagi S., Kishimoto H., Kawahara K., et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 117 (2007) 2929-2940
34. Dovey J.S., Zacharek S.J., Kim C.F., and Lees J.A. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci U S A 105 (2008) 11857-11862
35. Qian S., Ding J.Y., Xie R., et al. MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem Biophys Res Commun 377 (2008) 668-673